menu
    • menu

    Company profile for ImCheck Therapeutics

    NEW Drugs in Dev: 2
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    Topscience Biotech is a one-stop supplier of sodium hyaluronate//drug manufacturing license, CEP, GMP, DMF, and Form 41 certifications.

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    ImCheck Therapeutics is driving innovation in two powerful new areas of immune system modulation: the butyrophilins superfamily of immunomodulatory molecules and gamma-delta T cells. The company is developing next generation immunotherapeutics for patients with severe unmet medical needs with a primary focus on immuno-oncology. Our growing understanding of these novel targets has also identified unique opportunities in immun...
    ImCheck Therapeutics is driving innovation in two powerful new areas of immune system modulation: the butyrophilins superfamily of immunomodulatory molecules and gamma-delta T cells. The company is developing next generation immunotherapeutics for patients with severe unmet medical needs with a primary focus on immuno-oncology. Our growing understanding of these novel targets has also identified unique opportunities in immune-mediated inflammatory disease also known as autoimmune diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ImCheck TherapeuticsFrance Flag
    Country
    Country
    France
    Address
    Address
    31 chemin Joseph Aiguier CS 70071 13402, MARSEILLE Cedex 09
    Telephone
    Telephone
    +33 4 13 96 14 90
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.imchecktherapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/imcheck-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/ImcheckThx

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Herantis Taps Indivi for Digital Biomarkers in Parkinson's Trial
    Herantis Taps Indivi for Digital Biomarkers in Parkinson's Trial

    19 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/19/3297209/0/en/hephaistos-pharma-appoints-stephan-braun-as-chief-medical-officer-to-lead-clinical-development-strategy.html

    GLOBENEWSWIRE
    19 May 2026
    Share Share
    Ipsen Acquires Imcheck Therapeutics, Expands Oncology Pipeline
    Ipsen Acquires Imcheck Therapeutics, Expands Oncology Pipeline

    15 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/15/3205646/0/en/Ipsen-completes-acquisition-of-ImCheck-Therapeutics-expanding-oncology-pipeline.html

    GLOBENEWSWIRE
    15 Dec 2025
    Share Share
    Imcheck Shows Promising ICT01 Results In First-Line in AML At ASH
    Imcheck Shows Promising ICT01 Results In First-Line in AML At ASH

    07 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/07/3201152/0/en/ImCheck-Reports-Durable-Responses-and-Early-Overall-Survival-Signal-with-ICT01-in-First-line-AML-at-ASH-2025.html

    GLOBENEWSWIRE
    07 Dec 2025
    Share Share
    ImCheck Oral ICT01 Data in First-Line AML at 67th ASH Annual Meet
    ImCheck Oral ICT01 Data in First-Line AML at 67th ASH Annual Meet

    05 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/05/3200499/0/en/ImCheck-Announces-Oral-Presentation-of-ICT01-First-Line-AML-Data-at-the-67th-ASH-Annual-Meeting.html

    GLOBENEWSWIRE
    05 Dec 2025
    Share Share
    Ipsen Puts up $1.6B to Absorb ImCheck for Leukemia Antibody
    Ipsen Puts up $1.6B to Absorb ImCheck for Leukemia Antibody

    24 Oct 2025

    // BIOSPACE

    https://www.biospace.com/business/ipsen-puts-up-1-6b-to-absorb-imcheck-for-mid-stage-leukemia-antibody

    BIOSPACE
    24 Oct 2025
    Share Share
    ImCheck's ICT01 Gets EMA Orphan Drug Status for Myeloid Leukemia
    ImCheck's ICT01 Gets EMA Orphan Drug Status for Myeloid Leukemia

    21 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/21/3118620/0/en/ImCheck-s-Announces-EMA-Orphan-Drug-Designation-for-ICT01-as-Treatment-for-Acute-Myeloid-Leukemia.html

    GLOBENEWSWIRE
    21 Jul 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search